Thermo Fisher, Intrinsic Bioprobes Partner to Develop Mass Spec Assays

Thermo Fisher's sample handling and mass spectrometers will be integrated with IBI's proprietary immunoenrichment technology, and the two firms will develop assays and workflows for the detecting and quantifying low abundance proteins.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.